Heart Failure
Conditions
Brief summary
Despite its known prevalence in Heart Failure, a recent study conducted by Prof. Cacoub (unpublished) on the French national health insurance database showed that iron deficiency was a poorly diagnosed and poorly treated comorbidity. In chronic diseases including Heart Failure, Transferrin Saturation Factor is only performed in about 10% of cases while it is recommended for patients with Heart Failure (French Health High Authority 2011). The purpose of this study is to obtain current data on the prevalence of iron deficiency in France in patients with Heart Failure, applying the recommendations of European Society of Cardiology and French Health High Authority (determination of ferritinemia and Transferrin Saturation Factor).
Interventions
DIAGNOSTIC_TESTIron status testing
Blood sample for iron status testing
Sponsors
VIFORFRANCE
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient, male or female, over 18 years of age * Patient present at the hospital on the day of the study * Diagnosis of Heart Failure (acute or chronic) regardless of left ventricular ejection fraction (LVEF) * Patient with signed consent
Exclusion criteria
* Protected patient: major under guardianship, tutorship or other legal protection, deprived of liberty by judicial or administrative decision * Pregnant or breastfeeding woman
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Complete blood iron status | One day | ferritin, Transferrin Saturation Factor |
Outcome results
None listed